Clinical Trials Directory

Trials / Sponsors / Fresenius Kabi SwissBioSim GmbH

Fresenius Kabi SwissBioSim GmbH

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingReal World Use of Tocilizumab Biosimilar studY
Rheumatoid Arthritis
—2024-03-05
CompletedA Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Wom
Postmenopausal Osteoporosis
Phase 32021-06-16
CompletedMSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 32020-08-03
CompletedComparison of PK and Tolerability of MSB11022 Administered by AI or PFS
Rheumatoid Arthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis
Phase 12019-07-15
CompletedPharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456
Healthy
Phase 12017-11-27
CompletedPharmacokinetic/Pharmacodynamic Equivalence of MSB11455 in Healthy Subjects
Healthy
Phase 12017-08-22
CompletedSafety and Immunogenicity of MSB11455 in Healthy Participants
Healthy
Phase 12017-08-21
CompletedMSB11022 in Moderate to Severe Rheumatoid Arthritis
Moderate to Severe Rheumatoid Arthritis
Phase 32017-01-31
CompletedMSB11022 in Moderate to Severe Chronic Plaque Psoriasis
Psoriasis, Plaque Type Psoriasis, Moderate to Severe Plaque Psoriasis
Phase 32016-02-16
CompletedMSB11022 in Healthy Subjects
Healthy Subjects
Phase 12014-05-01